Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > US economic recovery

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Dec 07, 2020 12:41pm

190 Views

Post# 32049991

RE:US economic recovery

In my opinion it's cheerful gobbledegook. The pandemic is currently at it's height. When will the United States economy recover from the COVID-19 pandemic? Certainly not in 1Q21. Maybe 2Q21 or 3Q21? Theralase keep talking about launching US sites in 4Q20 and 1Q21, subject to impossible conditions.

Kingpin68 wrote: So, does anyone know what this really means, launching US sites pending economic recovery. Is it job numbers, stock market, Covid cases. What's the criteria ? Seems vague. Why should any of that stop US sites if the hospitals have capacity to do it.

<< Previous

Bullboard Posts

Next >>

Two micro-cap stocks with strong fundamentals